What are Carroll Patrick Harrison’s HIMS share holdings after these transactions?

After the reported RSU vesting and related tax withholding, Carroll Patrick Harrison directly holds 182,440 shares of Hims & Hers Health Class A Common Stock. This reflects his post-transaction ownership position shown in the non-derivative holdings section.

Hims & Hers (NYSE: HIMS) CMO reports RSU vesting and tax share withholding

Q: What insider transactions did HIMS Chief Medical Officer report on this Form 4?

The filing shows Carroll Patrick Harrison had multiple restricted stock unit awards vest and settle into Class A Common Stock on March 13, 2026, along with a share withholding transaction to cover associated tax obligations on the vested RSUs.

Q: How many HIMS Class A shares did the insider acquire through RSU vesting?

RSU awards for 8,149 , 4,840 and 3,533 units vested and converted into a total of 16,522 Class A Common shares . These conversions occurred at a stated conversion price of $0.00 per share as part of the equity compensation program.

Q: What is the vesting schedule for the HIMS RSUs in this insider filing?

The RSUs vest over four years under service-based requirements. One grant vests 25% on December 15, 2023 , with the remaining 75% vesting quarterly thereafter, while other grants vest in substantially equal quarterly installments starting June 15, 2024 and June 15, 2025.

Q: Were the HIMS insider transactions open-market buys or sales?

No open-market trades are reported. The Form 4 shows derivative exercises/conversions of RSUs into Class A shares and a tax-withholding disposition where shares were withheld by the issuer, rather than discretionary purchases or sales in the market.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Hims & Hers Health, Inc. director and Chief Medical Officer Carroll Patrick Harrison reported the vesting and settlement of restricted stock units into Class A Common Stock. On March 13, 2026, RSU awards for 8,149, 4,840 and 3,533 units converted into a total of 16,522 Class A shares at a conversion price of $0.00.

To satisfy tax withholding obligations related to this RSU vesting, 4,022 Class A shares were withheld by the issuer at $24.77 per share, a non‑market, tax-withholding disposition rather than an open-market sale. Following these transactions, Harrison holds 182,440 Class A Common shares directly.

Insider Trade Summary

16,522 shares exercised/converted

Mixed 5 txns

Insider Carroll Patrick Harrison

Role Chief Medical Officer

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Unit	8,149	$0.00	--
Exercise	Restricted Stock Unit	4,840	$0.00	--
Exercise	Restricted Stock Unit	3,533	$0.00	--
Exercise	Class A Common Stock	16,522	$0.00	--
Tax Withholding	Class A Common Stock	4,022	$24.77	$100K

Holdings After Transaction: Restricted Stock Unit — 24,446 shares (Direct); Class A Common Stock — 186,462 shares (Direct)

Footnotes (1)

The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. The shares of Class A Common Stock were withheld by the issuer to cover tax withholding obligations in connection with the reported vesting and settlement of RSUs. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 25% of the RSUs vesting on December 15, 2023, and the remaining 75% of the RSUs vesting in substantially equal quarterly installments over the following 3 years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date") occurring thereafter. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2024. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2025.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

03/17/2026 - 04:29 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Carroll Patrick Harrison

(Last)

(First)

(Middle)

2269 CHESTNUT STREET, #523

(Street)

SAN FRANCISCO

94123

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Hims & Hers Health, Inc. [ HIMS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Medical Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/13/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Class A Common Stock	03/13/2026		M		16,522	A	⁽¹⁾	186,462	D
Class A Common Stock	03/13/2026		F		4,022⁽²⁾	D	$24.77	182,440	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Restricted Stock Unit	⁽¹⁾	03/13/2026		M			8,149	⁽³⁾	⁽³⁾	Class A Common Stock	8,149	$0	24,446	D
Restricted Stock Unit	⁽¹⁾	03/13/2026		M			4,840	⁽⁴⁾	⁽⁴⁾	Class A Common Stock	4,840	$0	38,717	D
Restricted Stock Unit	⁽¹⁾	03/13/2026		M			3,533	⁽⁵⁾	⁽⁵⁾	Class A Common Stock	3,533	$0	42,397	D

Explanation of Responses:

1. The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.

2. The shares of Class A Common Stock were withheld by the issuer to cover tax withholding obligations in connection with the reported vesting and settlement of RSUs.

3. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 25% of the RSUs vesting on December 15, 2023, and the remaining 75% of the RSUs vesting in substantially equal quarterly installments over the following 3 years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date") occurring thereafter.

4. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2024.

5. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2025.

Remarks:

	/s/ Kimberly Mather, Attorney-in-Fact for Patrick Harrison Carroll	03/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What insider transactions did HIMS Chief Medical Officer report on this Form 4?

The filing shows Carroll Patrick Harrison had multiple restricted stock unit awards vest and settle into Class A Common Stock on March 13, 2026, along with a share withholding transaction to cover associated tax obligations on the vested RSUs.

How many HIMS Class A shares did the insider acquire through RSU vesting?

RSU awards for 8,149, 4,840 and 3,533 units vested and converted into a total of 16,522 Class A Common shares. These conversions occurred at a stated conversion price of $0.00 per share as part of the equity compensation program.

How were taxes handled for the HIMS RSU vesting reported in this Form 4?

To satisfy tax withholding obligations, the issuer withheld 4,022 Class A Common shares at a value of $24.77 per share. This is characterized as a tax-withholding disposition, not an open-market sale initiated by the insider.

What is the vesting schedule for the HIMS RSUs in this insider filing?

The RSUs vest over four years under service-based requirements. One grant vests 25% on December 15, 2023, with the remaining 75% vesting quarterly thereafter, while other grants vest in substantially equal quarterly installments starting June 15, 2024 and June 15, 2025.

Were the HIMS insider transactions open-market buys or sales?

No open-market trades are reported. The Form 4 shows derivative exercises/conversions of RSUs into Class A shares and a tax-withholding disposition where shares were withheld by the issuer, rather than discretionary purchases or sales in the market.